Oral delivery of <i>Kaempferia parviflora</i>'s methoxyflavones <i>via</i> nanostructured lipid carriers: Its effect on obesity and dyslipidemia treatment".

Int J Pharm X · 2025 · PMC12205846 · PMID 40584401

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

showed a trendno p-value reported

Both positive control (LCAR and ORSIT) and BG at all doses showed a trend toward reducing FER compared to the HFD group, but the reduction did not reach statistical significance ( p > 0.05 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Oral delivery of &lt;i&gt;Kaempferia parviflora&lt;/i&gt;'s methoxyflavones &lt;i&gt;via&lt;/i&gt; nanostructured lipid carriers: Its effect on obesity and dyslipidemia treatment".

The sentences

Oral delivery of <i>Kaempferia parviflora</i>'s methoxyflavones <i>via</i> nanostructured lipid carriers: Its effect on obesity and dyslipidemia treatment".